The virus is related to the pathogen that causes Middle East respiratory syndrome and capitalizes on the same ‘entry receptor ...
The CSIC-UNESPA scientific expedition has been underway since last January with the aim of monitoring the presence of the ...
GlobalData on MSN9h
Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP useThe US Food and Drug Administration (FDA) has accepted Gilead’s new drug application (NDA) for lenacapavir and set a prescription drug user fee act (PDUFA) target action date of ...
An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...
Sexually-transmitted infections have been on the rise for close to a decade, with the age group of 15-24 being the population ...
Days after the arrest of a former martial arts instructor at Leclerc's Martial Arts in Dutchess County, families and ...
Human immunodeficiency virus (HIV) treatment has gotten so good that people can take a pill once a day to achieve viral ...
With so much H5N1 circulating in the U.S., scientists worry we are a few mutations away from a potential human pandemic.
A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...
Hosted on MSN1d
Expand coverage, PhilHealth urgedSEN. Bong Go wants PhilHealth (Philippine Health Insurance Corp.) to expand coverage for tuberculosis (TB) and human ...
The proposal would impact 67% of the research funded by the National Institutes of Health in Puerto Rico’s public university system. #NewsismyBusiness #CPI #CentrodePeriodismoInvestigativo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback